Food intake is a complex behavior resulting from interactions between homeostatic and hedonic regulatory mechanisms acting in the energy balance and reward centers of the brain. Alterations in feeding behavior are often pervasive and can lead to obesity and its associated medical complications, including metabolic and cardiovascular disorders and psychological distress. A compelling body of evidence emerged recently, indicating a pivotal role of brain-derived neurotrophic factor (BDNF) in pathological processes leading to abnormal food intake and excessive weight gain. BDNF signals through the TrkB receptor to promote neuronal survival, differentiation, and synaptic plasticity. Perturbing central BDNF signaling in mice results in hyperphagic behavior and obesity (Xu et al, 2003; Unger et al, 2007). In humans, BDNF haploinsufficiency was linked to elevated food intake and severe weight gain (Han et al, 2008). These findings have significant clinical implications, as the BdnfVal66Met allele, which impedes regulated BDNF secretion, is highly prevalent in humans (Shimizu et al, 2004).
Previous work indicated that hypothalamic BDNF participates in homeostatic processes that preserve energy levels essential for survival. Recently, we demonstrated an intimate involvement of BDNF in the regulation of hedonic feeding via the positive modulation of the mesolimbic dopamine pathway (Cordeira et al, 2010). This neural circuit mediates motivated and reward-seeking behaviors, including consumption of palatable food, and has well-established roles in drug addiction. Mice with selective deletion of Bdnf in the ventral tegmental area (VTA), a principal source of mesolimbic BDNF, consumed significantly more palatable high-fat food than control mice, while exhibiting normal intake of standard chow. Furthermore, evoked release of dopamine by mesolimbic fibers in the nucleus accumbens was diminished in mice lacking central BDNF, suggesting decreased VTA dopamine neuron activity and concomitant reductions in neurotransmitter release. It was proposed previously that hypoactivity of the mesolimbic system might result in reward deficiency syndrome and, behaviorally, in compensatory overeating to enhance a deficient dopaminergic system. In support of this model, hyperphagic leptin-deficient mice were also reported to have reduced evoked dopamine release in the nucleus accumbens (Fulton et al, 2006). Moreover, we found that administration of a dopamine-1 receptor agonist abrogated overeating in BDNF mutant mice. The results argue strongly that BDNF is a natural modulator of hedonic food intake and that dysregulation of BDNF signaling in the reward circuitry increases the drive to eat in the absence of a homeostatic requirement.
BDNF facilitates synaptic sensitization of VTA dopamine neurons following cocaine withdrawal, which might represent a mechanism mediating cue-associated drug craving and relapse (Pu et al, 2006). Many questions remain regarding the effects of BDNF on excitability within the VTA during food reward-related processes. For example, does BDNF facilitate forms of synaptic plasticity in the VTA necessary for food reward learning? Does deficient BDNF signal affect the firing rate of dopamine neurons and impede transitions to burst firing and subsequent dopamine release during food reward-related processes? A better understanding of the cellular and molecular mechanisms underlying the anorexigenic effects of this pleiotropic neurotrophin will facilitate the development of novel therapies for appetitive disorders.
References
Cordeira J, Frank L, Sena-Esteves M, Pothos E, Rios M (2010). Brain-derived neurotrophic factor regulates hedonic feeding by acting on the mesolimbic dopamine system. J Neurosci 30: 2533–2541.
Fulton S, Pissios P, Manchon RP, Stiles L, Frank L, Pothos EN et al (2006). Leptin regulation of the mesoaccumbens dopamine pathway. Neuron 51: 811–822.
Han JC, Liu QR, Jones M, Levinn RL, Menzie CM, Jefferson-George KS et al (2008). Brain-derived neurotrophic factor and obesity in the WAGR syndrome. N Engl J Med 359: 918–927.
Pu L, Liu QS, Poo MM (2006). BDNF-dependent synaptic sensitization in midbrain dopamine neurons after cocaine withdrawal. Nat Neurosci 9: 605–607.
Unger TJ, Calderon GA, Bradley LC, Sena-Esteves M, Rios M (2007). Selective deletion of Bdnf in the ventromedial and dorsomedial hypothalamus of adult mice results in hyperphagic behavior and obesity. J Neurosci 27: 14265–14274.
Shimizu E, Hashimoto K, Iyo M (2004). Ethnic difference of the BDNF 196G/A (val66met) polymorphism frequencies: the possibility to explain ethnic mental traits. Am J Med Genet B Neuropsychiatr Genet 126: 122–123.
Xu B, Goulding EH, Zang K, Cepoi D, Cone RD, Jones KR et al (2003). Brain-derived neurotrophic factor regulates energy balance downstream of melanocortin-4 receptor. Nat Neurosci 6: 736–742.
Acknowledgements
This work was supported by the Klarman Family Foundation and NIDDK (DK073311) research grants to MR.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Competing interests
The author declares that during the past 3 years, she has been compensated for offering scientific opinions to Wyeth Pharmaceuticals. This does not reflect a conflict of interest with respect to this article.
Rights and permissions
About this article
Cite this article
Rios, M. New Insights into the Mechanisms Underlying the Effects of BDNF on Eating Behavior. Neuropsychopharmacol 36, 368–369 (2011). https://doi.org/10.1038/npp.2010.139
Published:
Issue Date:
DOI: https://doi.org/10.1038/npp.2010.139
This article is cited by
-
BDNF genetic variability modulates psychopathological symptoms in patients with eating disorders
European Child & Adolescent Psychiatry (2014)